Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients

NCT: NCT02241252 · COMPLETED

NCT IDNCT02241252
StatusCOMPLETED
Start Date2013-09
Completion2015-05

Brief Summary

This study will validate the recording accuracy of a specific electrical interval of the heart, the QT interval, between an iPhone rhythm strip recording and a traditional 12-lead electrocardiogram (ECG). These measurements will occur in hospitalized patients that are starting either sotalol or dofetilide, since both of these medications can prolong the QT interval.

Frequently Asked Questions

What is Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients?

Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients is a clinical trial registered under NCT02241252. Current status: COMPLETED.

What is the status of NCT02241252?

The current status of NCT02241252 (Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients) is: COMPLETED.

When did Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients start?

Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients started on 2013-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑